LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.10
+0.01 (0.16%)
Apr 28, 2025, 4:00 PM EDT - Market closed
LifeMD Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for LifeMD stock have an average target of 11.17, with a low estimate of 7.00 and a high estimate of 15. The average target predicts an increase of 83.11% from the current stock price of 6.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for LifeMD stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +129.51% | Mar 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +145.90% | Mar 11, 2025 |
| Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +14.75% | Jan 8, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +96.72% | Dec 10, 2024 |
| Mizuho | Mizuho | Hold Initiates $7 | Hold | Initiates | $7 | +14.75% | Dec 4, 2024 |
Financial Forecast
Revenue This Year
274.24M
from 212.45M
Increased by 29.08%
Revenue Next Year
325.83M
from 274.24M
Increased by 18.81%
EPS This Year
-0.06
from -0.53
EPS Next Year
0.19
from -0.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 285.6M | 367.2M | 478.5M |
| Avg | 274.2M | 325.8M | 409.3M |
| Low | 260.3M | 291.7M | 354.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 34.4% | 33.9% | 46.9% |
| Avg | 29.1% | 18.8% | 25.6% |
| Low | 22.5% | 6.3% | 8.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.23 | 0.32 | 0.60 |
| Avg | -0.06 | 0.19 | 0.51 |
| Low | -0.25 | 0.07 | 0.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 217.2% |
| Avg | - | - | 170.3% |
| Low | - | - | 123.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.